Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · IEX Real-Time Price · USD
3.310
-0.010 (-0.30%)
At close: Jul 26, 2024, 4:00 PM
3.250
-0.060 (-1.81%)
After-hours: Jul 26, 2024, 7:02 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $126.87 million as of July 26, 2024. Its market cap has increased by 13.68% in one year.
Market Cap
126.87M
Enterprise Value
5.65M
1-Year Change
13.68%
Ranking
Category
Stock Price
$3.31
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $126.87M, a decrease of -74.10%. That is a compound annual growth rate of -29.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 126.90M | 37.19% |
| Dec 29, 2023 | 92.50M | -22.85% |
| Dec 30, 2022 | 119.90M | -75.36% |
| Dec 31, 2021 | 486.70M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.13% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunic | 129.70M |
| American Well | 129.22M |
| Inventiva | 128.72M |
| DIH Holdings US | 127.92M |
| Electromed | 127.50M |
| Akoya Biosciences | 121.98M |
| Relmada Therapeutics | 121.16M |
| Nuvectis Pharma | 120.97M |